Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Paco M. W. Welsing"'
Autor:
Paco M. W. Welsing, Floris Lafeber, Janneke Tekstra, Jacob M. van Laar, Anton Westgeest, Maxime Verhoeven, Johannes W G Jacobs
ObjectivesTo establish the value of a modified DAS (DAS-OST) without joint counts but with a HandScan score (OST), versus that of DAS28, to classify RA as active versus inactive, with as reference standard the rheumatologist's clinical classification
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e72af3858f6b9ee9d4c915c7ada72919
https://doi.org/10.21203/rs.3.rs-566581/v1
https://doi.org/10.21203/rs.3.rs-566581/v1
Autor:
Roger Hesselstrand, Reinhard E. Voll, Ellen De Langhe, Per Ljungman, Jeska K de Vries-Bouwstra, Madelon C. Vonk, Vanessa Smith, Miro Mayer, Anne C. A. Marijnissen, Jacob M van Laar, Nicoletta Del Papa, Karina Roxana Gheorghe, Paco M. W. Welsing, Anna van Rhenen, Dirk M. Wuttge, Roland Schroers, Tessa Kerre, Erik W.A. Marijt, Julia Spierings, Marc Schmalzing, Arjan A. van de Loosdrecht, Joerg Henes, Ulrich A. Walker, Alexandre E Voskuyl, Daan Dierickx
Publikováno v:
BMJ Open, 11
BMJ Open, 11(3). BMJ PUBLISHING GROUP
BMJ Open, 11, 3
BMJ Open, 11(3):e044483. BMJ Publishing Group
BMJ Open, Vol 11, Iss 3 (2021)
BMJ OPEN
Spierings, J, van Rhenen, A, Welsing, P M W, Marijnissen, A C A, de Langhe, E, del Papa, N, Dierickx, D, Gheorghe, K R, Henes, J, Hesselstrand, R, Kerre, T, Ljungman, P, van de Loosdrecht, A A, Marijt, E W A F, Mayer, M, Schmalzing, M, Schroers, R, Smith, V, Voll, R E, Vonk, M C, Voskuyl, A E, de Vries-Bouwstra, J K, Walker, U A, Wuttge, D M & van Laar, J M 2021, ' A randomised, open-label trial to assess the optimal treatment strategy in early diffuse cutaneous systemic sclerosis: The UPSIDE study protocol ', BMJ Open, vol. 11, no. 3, e044483 . https://doi.org/10.1136/bmjopen-2020-044483
BMJ Open
BMJ Open, 11(3). BMJ PUBLISHING GROUP
BMJ Open, 11, 3
BMJ Open, 11(3):e044483. BMJ Publishing Group
BMJ Open, Vol 11, Iss 3 (2021)
BMJ OPEN
Spierings, J, van Rhenen, A, Welsing, P M W, Marijnissen, A C A, de Langhe, E, del Papa, N, Dierickx, D, Gheorghe, K R, Henes, J, Hesselstrand, R, Kerre, T, Ljungman, P, van de Loosdrecht, A A, Marijt, E W A F, Mayer, M, Schmalzing, M, Schroers, R, Smith, V, Voll, R E, Vonk, M C, Voskuyl, A E, de Vries-Bouwstra, J K, Walker, U A, Wuttge, D M & van Laar, J M 2021, ' A randomised, open-label trial to assess the optimal treatment strategy in early diffuse cutaneous systemic sclerosis: The UPSIDE study protocol ', BMJ Open, vol. 11, no. 3, e044483 . https://doi.org/10.1136/bmjopen-2020-044483
BMJ Open
IntroductionSystemic sclerosis (SSc) is a chronic, autoimmune connective tissue disease associated with high morbidity and mortality, especially in diffuse cutaneous SSc (dcSSc). Currently, there are several treatments available in early dcSSc that a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::efe321de3f3691e61f10c0c390a3e5bd
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/232577
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/232577